Nuvectis Pharma Inc (NVCT)
Healthcare
Biotechnology
21.60 $
+0.4%
vs. previous close
Closing price · As of: 3. Aug 2026
Nuvectis Pharma Inc (NVCT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -16 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 0.0 | -9.5 | -14 | -16 | -12 | -16 | |
| – | 1.9 | 1.7 | 4.7 | 4.9 | 1.4 | |
| 1.9 | 1.9 | 1.7 | – | – | – | |
| 0.0 | 1.5 | 3.8 | 1.7 | 1.9 | 4.4 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| – | – | 28 | – | – | – | |
| 15 | 15 | 28 | 15 | 12 | 29 | |
| 0.0 | 5.7 | 14 | -0.9 | -0.6 | 13 | |
| 0.0 | -9.5 | -14 | -16 | -12 | -16 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.